Infant Clinical Nutrition Market

Infant Clinical Nutrition Market Outlook (2023-2033)

Expanding at a CAGR of 6%, the global infant clinical nutrition market is projected to increase from a valuation of US$ 25,980.3 Mn in 2023 to US$ 45,733.7 Mn by 2033.

Infant Clinical Nutrition Consumption Analysis (2017-2022) Vs. Market Estimations (2023-2033)

The global infant clinical nutrition market in the historical period registered a CAGR of 6.2% and is expected to value at US$ 25,980.3 Mn in 2023. Malnutrition in children prevails as a grave concern worldwide. Increasing birth rate coupled with mounting number of premature births has led toward demand for nutrition-rich supplements for young infants. Extremely preterm infants require high nutrition supply that is challenging to meet as growth faltering is common. In adequate growth has further been linked with poor neurodevelopmental outcomes. Although improved early growth in children is associated with good cognitive outcomes, possibility of a trade-off based on worse metabolic outcomes exists.

Several new developments have been witnessed in infant clinical nutrition that include recommendations on increasing protein supply, improving lipid formulations, and providing mineral supplements while promoting human milk feeding. Focus of researches carried out on infant clinical nutrition is being directed toward new formula products with potential of improving metabolic and cognitive outcomes. Provision of effective nutrition to infants is being prioritized as an imperative focus of researches associated with neonatal care, with an aim of improving long-term developmental and metabolic outcomes.

The National Health Service has recently published standards that mandate screening of all infants for undernutrition post-birth along with periodic examinations. Researchers across the globe are focusing on the development of appropriate nutritional screening tools for children on admission. These tools are likely to facilitate identification of infants who are at high risk of undernutrition as well as those who are undernourished, further benefitting from referral for complete nutritional assessment with the help of a dietician. The market is likely to slowly expand based on the market trends and attain a valuation of US$ 45,733.7 Mn and a CAGR of 6% for the forecast duration.

What are the Key Trends in the Market for Infant Clinical Nutrition?

“Increasing Birth Rate with the Growing Number of Premature Births Creates Needs for Infant Nutrition Supplements”

The world population is increasing with the mounting birth rate in developing countries in the world. Governments in many developed countries are making efforts to rise the birth rate. At the same time, the number of premature births in the world has reached its peak since past few years. The World Health Organization (WHO) estimates that over 15 million babies born preterm each year. Preterm birth can create complications that are dire enough to prove fatal and become one of the leading causes of death among children. In order to boost the survival rate of premature infants, need for effective, nutrition-rich supplements is increasing worldwide. With many governments and authoritative organizations in the world making efforts to improve the outcomes of preterm births, demand for infant clinical nutrition is likely to increase in coming years.

“Growing Consumer Awareness About the Infant Needs for Nutritional Supplements to Stimulate the Market Growth”

Since the past few years, the gender gap in the labor market and employment statistic in the world has been narrowing at a steadily increasing pace. As stated by the International Labor Organization (ILO), female labor force participation in the global labor force was over 49.6% in 2015, and it is likely to increase in coming years. Many women across the globe are joining the labor force along with men, which makes a significant impact on the global birth rate. Women are leading a lifestyle that is as busy as that followed by men. With the increasing participation of women in the labor force, household income of consumers has been observed to be increasing significantly. As a result of increasing awareness about nutritional needs of infants, busy lifestyle adopted by women, and rise in household incomes, demand for infant clinical nutrition is growing rapidly.

“Consumer Demand for Premium Quality Products to Positively Impact the Market”

Growing awareness about the nutritional requirements of new-born babies is leading to increased demand for high-quality infant nutrition food products in the world. Also, increasing trends of globalization and urbanization, and busier lifestyle led by consumers around the globe is boosting the sales of infant formula products. Increasing number of working mothers around the world is creating more demand for nutrition-rich supplements for their babies. With the increasing household income and high awareness about the infant health fundamentals, consumers are ready to pay extra for high-quality or premium nutrition products for their babies. Owing to the constant advancements in biotechnology and rising purchasing capability of consumers, manufacturers around the world are increasing the production of infant clinical nutrition products.

“Advancements in the Nutritional Modifications in the Infant Food Products to Boost the Market Growth”

With the increasing demand for highly effective infant formulas, manufacturers around the world are taking steps to improve the quality of infant nutrition products even more. By making use of advanced technologies and investing more in research, leading market players are developing nutrition-rich supplements for infants. Manufacturers are making use of a variety of ingredients in order to achieve improve metabolic outcomes. With the help of advanced neonatal care researches, it has become possible of market players to attain long-term developmental outputs of infant clinical nutritional products. The global infant clinical nutrition market is expected to witness the introduction of highly advanced and efficient products in upcoming years. Different types of advanced clinical nutrition products for infants such as milk-based, soy-based, probiotic/prebiotic, and organic products are among the popular infant clinical nutrition products in the global market

“Strict Regulations and Standards May Lead to Create Challenges for Manufacturers”

In order to ensure the quality and efficacy of infant clinical nutrition products, most governments in the world impose stringent rules and standards on manufacturers and distributors. Various regulatory bodies in the world such as the U.S. Food and Drug Administration (FDA), the European Food Safety Authority (EFSA), and Canadian Food Inspection Agency have developed strict regulations that all manufacturers have to comply with. By setting nutrient specifications and labeling requirements for infant foods, regulatory agencies regulate infant clinical nutrition products. Manufacturers have to submit the product specifications at least 90 days prior to marketing their products in the U.S., which indicates prolonged approval procedures. These stringent federal regulations may lead to result in increased manufacturing costs; manufacturers may have to make significant changes in their manufacturing process in some cases.

Country-wise insights

How is the North American Infant Clinical Nutrition Market Faring?

North American market holds 18.90% of the global share while U.S. held 16.70% of the market in 2022.

The infant clinical nutrition market in North America is rapidly developing due to advances in food nutrition and greater focus of individuals towards well-being of their children. The positive impacts of clean label food and food products have been gathering traction in the global market as well.

How is the European Infant Clinical Nutrition Market Faring?

European market for infant clinical nutrition holds 23% of the market value share in 2022.

The foodservice industry is becoming increasingly popular which has led to the rapid expansion and prominent growth. Capital investments into the sector anticipating rising demand has resulted in segment wise development as well.

Category-wise insights

Which Product Type of Infant Clinical Nutrition Accounts for High Revenue Generation?

Milk-Based segment is expected to dominate the infant clinical nutrition market in revenue terms in 2023, and is expected to continue to do so throughout the forecast period.

The powder segment is expected to account for an 73.3% value share in 2022, and is projected to account for an even higher share by 2032 end.

Which Route of Administration of Infant Clinical Nutrition is seen more across the World?

Oral administration is expected to dominate the global infant clinical nutrition market in revenue terms in 2023, and is projected to continue to do so throughout the forecast period. This is due to it being the easiest mode to feed the children.

The oral administration segment is expected to account for an 83.4% value share in 2023.

Competitive Dashboard

The global market is primarily characterized by a large number of multinational players that occupy major share of the market. The presence of multinational players is responsible for high monetary investment into development of new technologies to improve efficiency of the production process and optimize supply chains with gradual rise in demand. Influx of capital into branding and promotion of their respective products helps attract new customers and consolidate the existing customer base.

• In 2015, the Abbott Laboratories entered into a contract to acquire Tendyne Holdings, a private medical device company that has placed primacy focus in order to develop a minimally invasive mitral valve replacement therapy. The acquisition was completed in September, 2015.
• In 2017, Baxter announced its mutual agreement with a global contract research and development (R&D) body: Dorizoe Lifesciences Limited (Dorizoe), in order to facilitate accelerated development of over 20 injectable products (generics) including oncolytics, anti-invective’s, and cardiovascular medicines.
• In March 2016, Nestle’s subsidiary, Nestle Skin Health S.A entered into a definitive agreement with Guthy-Renker LLC, which happens to be a prominent direct marketing establishment in order to acquire a majority percentage in the joint venture company, The Proactiv Company (Proactiv), a brand offering non-prescription acne medication.
• In 2016, Reckitt Benckiser Group Plc entered into a contract to acquire Hypermarcas’ business involving Brazilian condom and lubricants. Hypermarcas is one the leading Brazilian condom manufacturers, through its three brands such as Jontex, Olla and Lovetex. The addition of these brands enhances RB’s sexual wellbeing footprint in Brazil while in July 2017, McCormick & Co announced the acquisition of Reckitt’s food business for US$4.2 billion.

Infant Clinical Nutrition Industry Report Scope

Infant Clinical Nutrition Industry Research by Category

By Product Type:

• Milk-Based
• Soy-Based
• Organic
• Probiotic/Prebiotic

By Route of Administration:

• Oral administration
• Enteral administration
• Intravenous administration

By Region:

• North America
• Latin America
• Europe
• South Asia & Pacific
• East Asia
• Middle East & Africa

To know more about delivery timeline for this report Contact Sales